Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of P27Kip1 in the acute promyelocytic leukemia cell line NB4

被引:28
作者
Kardinal, C
Dangers, M
Kardinal, A
Koch, A
Brandt, DT
Tamura, T
Welte, K
机构
[1] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany
[2] Univ Munich, Lehrstuhl Angew Phys, Munich, Germany
[3] Univ Heidelberg, Inst Pharmakol, D-6900 Heidelberg, Germany
关键词
D O I
10.1182/blood-2005-05-1771
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated the role of tyrosine phosphorylation of the cyclin-dependent kinase (cdk) inhibitor p27(Kip1) using the acute promyelocytic leukemia cell line NB4 together with granulocyte colony-stimulating factor (G-CSF). Short-term G-CSF stimulation resulted in a rapid tyrosine dephosphorylation of p27(Kip1) accompanied by a change in its binding preferences to cdks. On G-CSF stimulation, p27(Kip1) dissociated from cdk4 and associated with cdk2. Binding assays with recombinant p27(Kip1) confirmed that tyrosine-phosphorylated p27(Kip1) preferentially bound to cdk4, whereas unphosphorylated protein preferentially associated with cdk2. In addition, studies with p27(Kip1) point mutations revealed a decisive role of Tyr88 and Tyr89 in binding to cdk4. Furthermore, phosphorylation of Tyr88 and Tyr89 was accompanied by strong nuclear translocation of p27(Kip1). Taken together, this report provides the first evidence that tyrosine phosphorylation of p27(Kip1) plays a crucial role in binding to cdks and its subcellular localization. Moreover, both effects are mediated by application of G-CSF.
引用
收藏
页码:1133 / 1140
页数:8
相关论文
共 28 条
[11]   Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor [J].
Jansen, JH ;
de Ridder, MC ;
Geertsma, WMC ;
Erpelinck, CAJ ;
van Lom, K ;
Smit, EME ;
Slater, R ;
van der Reijden, BA ;
de Greef, GE ;
Sonneveld, P ;
Löwenberg, B .
BLOOD, 1999, 94 (01) :39-45
[12]   Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1) [J].
Kiyokawa, H ;
Kineman, RD ;
ManovaTodorova, KO ;
Soares, VC ;
Hoffman, ES ;
Ono, M ;
Khanam, D ;
Hayday, AC ;
Frohman, LA ;
Koff, A .
CELL, 1996, 85 (05) :721-732
[13]   p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding [J].
Lacy, ER ;
Filippov, I ;
Lewis, WS ;
Otieno, S ;
Xiao, LM ;
Weiss, S ;
Hengst, L ;
Kriwacki, RW .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (04) :358-364
[14]   PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest [J].
Liang, J ;
Zubovitz, J ;
Petrocelli, T ;
Kotchetkov, R ;
Connor, MK ;
Han, K ;
Lee, JH ;
Ciarallo, S ;
Catzavelos, C ;
Beniston, R ;
Franssen, E ;
Slingerland, JM .
NATURE MEDICINE, 2002, 8 (10) :1153-1160
[15]   A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase [J].
Malek, NP ;
Sundberg, H ;
McGrew, S ;
Nakayama, K ;
Kyriakidis, TR ;
Roberts, JM .
NATURE, 2001, 413 (6853) :323-327
[16]   Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia [J].
Matsui, W ;
Smith, BD ;
Vala, M ;
Beal, N ;
Huff, CA ;
Diehl, LF ;
Jones, RJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (06) :853-862
[17]   p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation [J].
Moeller, SJ ;
Head, ED ;
Sheaff, RJ .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (11) :3735-3752
[18]   Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors [J].
Nakayama, K ;
Ishida, N ;
Shirane, M ;
Inomata, A ;
Inoue, T ;
Shishido, N ;
Hori, I ;
Loh, DY ;
Nakayama, K .
CELL, 1996, 85 (05) :707-720
[19]   Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells [J].
Rane, SG ;
Mangan, JK ;
Amanullah, A ;
Wong, BC ;
Vora, RK ;
Liebermann, DA ;
Hoffman, B ;
Graña, X ;
Reddy, EP .
BLOOD, 2002, 100 (08) :2753-2762
[20]   CDK inhibitors:: positive and negative regulators of G1-phase progression [J].
Sherr, CJ ;
Roberts, JM .
GENES & DEVELOPMENT, 1999, 13 (12) :1501-1512